Get started
Award

Sfb 1709/1 2025—533056198

Funded outputs count: 9
Funder award ID: SFB 1709/1 2025—533056198
OpenAlex ID: G761374745
A platform of serially transplantable AML PDX models covering subgroups for which no cell lines exist
2026 · Binje Vick, Vindi Jurinovic, et al. · HemaSphere · 1
PDF
Machine learning for population-level risk prediction of future cholangiocarcinoma
2026 · Felix van Haag, Jan Clusmann, et al. · EBioMedicine
Latent effector T cells mediate immunotherapy responses in the bone marrow microenvironment
2026 · Niklas Kehl, Tim R. Wagner, et al. · Cancer Cell · 3
PDF
msBayesImpute as a versatile framework for addressing missing values in biomedical mass spectrometry proteomics data
2026 · Jiaojiao He, Barbara Helm, et al. · Communications Chemistry · 1
PDF
Leukemic stem cell subtypes determine venetoclax resistance and therapeutic vulnerabilities in AML
2026 · Alexander Waclawiczek, Aino-Maija Leppä, et al. · Cell stem cell · 9
Primary CD34 + cells of patients with vacuoles, E1 enzyme, X‐linked, autoinflammatory, somatic (VEXAS) syndrome are highly sensitive to targeted treatment with TAK‐243
2025 · Daniel Nowak, Marie Demmerle, et al. · British Journal of Haematology · 1
PDF
Integrated scFv identification and CAR T cell generation for AML targeting in vivo
2025 · Yi Liu, Annika Lauk, et al. · International Journal of Cancer · 1
Resolving leukemic stem cell heterogeneity and plasticity with single-cell multiomics
2025 · Frank Y. Huang, Andreas Trumpp, et al. · Seminars in Hematology · 7
IBDome: An Integrated Molecular, Histopathological, and Clinical Atlas of Inflammatory Bowel Diseases
2025 · Christina Plattner, Gregor Sturm, et al. · Gastroenterology · 8
PDF
Year
Topic